Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | Director | May 12, 2022 | May 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date May 12, 2022 · Filed May 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,908 |
Reported balance
After 2022-05-12 transaction · row 1
1 source rowRow 1 · 2022-05-12 · Grant · Acquired 6,693 · Balance 7,908 F1: Reflects a grant of restricted stock units that vests on May 12, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vests on May 12, 2023.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
R1 RCM Inc. /DE
Report date November 19, 2024 · Filed November 19, 2024
Section 16 reporting ended · disclosed 2024-11-19. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Signify Health, Inc.
Report date March 29, 2023 · Filed March 29, 2023
Section 16 reporting ended · disclosed 2023-03-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-03-29 transaction · row 1
1 source rowRow 1 · 2023-03-29 · Disposition to issuer · Disposed 14,672 · Balance 0 F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2023 Filed Mar 29, 2023 08:47 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass A Common Stock | 14,672 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009919 · doc4.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. F1 · price: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. Read SEC document |
| May 19, 2022 Filed May 23, 2022 19:33 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 14,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-009035 · dp173671_4-holt.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · shares: Represents a grant of restricted stock units on May 19, 2022 that will vest on the first anniversary of the grant date. F2 · balance_after: The reporting person has assigned to New Mountain Capital, LLC all the rights, title and interest in the restricted stock units and disclaims beneficial ownership of the restricted stock units. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:16 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 6,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000129 · wf-form4_165273934225293.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,908 F1 · kind: Reflects a grant of restricted stock units that vests on May 12, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 18:34 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-22-000090 · wf-form4_164919802517660.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215 F1 · kind: Reflects a grant of restricted stock units that vests on May 11, 2022. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 18:10 UTC | Signify Health, Inc. SGFY · Entity 114996 | OtherClass A Common Stock | 7,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-002873 · dp167454_4-holt.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents the assignment of shares of Class A Common Stock acquired upon vesting of restricted stock units to New Mountain Capital, LLC ("New Mountain") pursuant to an assignment agreement between the reporting person and New Mountain. The reporting person disclaims beneficial ownership of the restricted stock units and the underlying shares of Class A Common Stock. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 20:00 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 7,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-002443 · dp146246_4-holt.xml · nonDerivative · entry 1 Holt Matthew S. · CIK 0001631836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,916 F1 · shares: Represents a grant of restricted stock units on February 16, 2021 that will vest on the first anniversary of the grant date. F2 · balance_after: The reporting person has assigned to New Mountain Capital, LLC all the rights, title and interest in the restricted stock units and disclaims beneficial ownership of the restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.